On 12 JUNE EXACT Sciences Corporation (NASDAQ:EXAS) reported ($0.23) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.19) by $0.04. The company had revenue of $0.30 million for the quarter, compared to the consensus estimate of $0.40 million. During the same quarter in the previous year, the company posted ($0.17) earnings per share. The company’s revenue for the quarter was down 70.0% on a year-over-year basis. On average, analysts predict that EXACT Sciences will post $-1.05 earnings per share for the current fiscal year. EXACT Sciences Corporation (NASDAQ:EXAS) weekly performance is 5.81%. On last trading day company shares ended up $16.20. Analysts mean target price for the company is $18.64. EXACT Sciences Corporation (NASDAQ:EXAS) distance from 50-day simple moving average (SMA50) is 23.64%.
Supernus Pharmaceuticals Inc (NASDAQ:SUPN) announced that United Therapeutics Corporation (NASDAQ:UTHR) has paid Supernus a $2 million milestone payment under United Therapeutics’ license agreement with Supernus. This payment was due upon the launch of Orenitram™ (treprostinil) Extended-Release Tablets for the treatment of pulmonary arterial hypertension, in the United States. Orenitram™ utilizes a Supernus patented technology platform. Supernus Pharmaceuticals Inc (NASDAQ:SUPN) shares advanced 2.25% in last trading session and ended the day on $10.46. SPUN return on assets is -77.00%. Supernus Pharmaceuticals Inc (NASDAQ:SUPN) quarterly performance is 5.66%.
On 9 JUNE LifePoint Hospitals, Inc. (NASDAQ:LPNT) reported $0.78 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.65 by $0.13. The company had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $1,000.00 million. During the same quarter in the prior year, the company posted $0.79 earnings per share. The company’s quarterly revenue was up 8.2% on a year-over-year basis. Analysts expect that LifePoint Hospitals will post $2.70 EPS for the current fiscal year. LifePoint Hospitals, Inc. (NASDAQ:LPNT) shares moved down -0.08% in last trading session and was closed at $64.33, while trading in range of $63.83 – $65.07. LifePoint Hospitals, Inc. (NASDAQ:LPNT) year to date (YTD) performance is 21.74%.
Magellan Health Inc (NASDAQ:MGLN) said it will hold an investor conference (the “Conference”) in New York, New York. The Conference will feature presentations by the Company’s executive management team highlighting the Company’s business strategy to deliver long-term growth and enhance shareholder value, including specifics related to its various businesses. Magellan Health Inc (NASDAQ:MGLN) ended the last trading day at $62.36. Company weekly volatility is calculated as 1.09% and price to cash ratio as 3.88. Magellan Health Inc (NASDAQ:MGLN) showed a positive weekly performance of 0.82%.
On 3 JUNE Sirona Dental Systems, Inc. (NASDAQ:SIRO) announced the expansion of its distribution with Henry Schein, Inc. in France effective immediately. Henry Schein will acquire the assets of ’s direct distribution business in Paris and Normandy, and coupled with the acquisition of other businesses in France with exclusive regional distribution agreements for products made by Sirona, will now exclusively distribute the entire Sirona product portfolio to the vast majority of France. Financial terms of the transaction were not disclosed. Sirona Dental Systems, Inc. (NASDAQ:SIRO) net profit margin is 13.90% and weekly performance is 0.39%. On last trading day company shares ended up $77.85. Analysts mean target price for the company is $81.69. Sirona Dental Systems, Inc. (NASDAQ:SIRO) distance from 50-day simple moving average (SMA50) is 3.62%.